tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Rick Bienkowski, 9 are a HOLD (21.43%), 33 are a BUY (78.57%).
Analyst Rick Bienkowski, carries an average stock price target met ratio of 10.56% that have a potential upside of 13.6% achieved within 65 days. Previously, Rick Bienkowski worked at CANTOR FITZGERALD, LEERINK.
Rick Bienkowski’s has documented 77 price targets and ratings displayed on 6 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on BEAM, Beam Therapeutics at 19-Aug-2025.
Analyst best performing recommendations are on VERV (VERVE THERAPEUTICS).
The best stock recommendation documented was for VERV (VERVE THERAPEUTICS) at 2/1/2023. The price target of $21 was fulfilled within 8 days with a profit of $1.07 (4.85%) receiving and performance score of 6.06.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 02-Mar-2020
$28
$0.77 (2.83%)
$65
Buy Since 23-Jul-2024
$80
$52.77 (193.79%)
$80
2 months 7 days ago
(25-Aug-2026)
0/20 (0%)
$48.97 (157.82%)
Buy Since 28-Mar-2025
$47
$19.77 (72.60%)
$47
3 months 24 days ago
(08-Jul-2026)
0/3 (0%)
$10.12 (27.44%)
Buy Since 11-May-2023
$68
$40.77 (149.72%)
$56
7 months 6 days ago
(26-Mar-2026)
0/3 (0%)
$44.38 (187.89%)
Buy Since 07-Nov-2022
$47
$19.77 (72.60%)
$77
7 months 7 days ago
(25-Mar-2026)
0/4 (0%)
$23.88 (103.29%)
